sofosbuvir and daclatasvir - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 outpatients
sofosbuvir and daclatasvir	Roozbeh

1 studies excluded by filtering options 1

6516

Eslami, 2020

1

31

0

not a RCT

risk of bias not avaialble